Within the ESG investment, the managers are paying special attention to those companies that help to meet the Paris objectives in relation to climate change, whose aim was to limit annual warming by 2C at most in relation to pre-industrial levels.
As Petra Daroczi, ESG fixed income analyst at Aberdeen Standard Investments, pointed out, long-term investors have a chance to take care of our planet’s environment.
Not only because it may be the “right thing to do”, but also because the most resilient companies will survive in the long term and offer more sustainable returns.
Which companies do the managers invest in? The investment focus is on those companies that are already meeting decarbonization targets.
By including bonds, “a viable decarbonization strategy would help in part to ensure that the company’s business is resilient, that it will be able to generate cash flow, pay off its debt and continue to access capital markets at a reasonable cost of financing,” said Darozci.
Find out more details about the importance of the transition to a low-carbon economy and read the latest business news with our companion app, Born2Invest.
In the long run, these investments are more resilient and profitable
The transition to a low-carbon economy is particularly challenging for the public service sector in the Asia Pacific region, given its dependence on low-cost, high-volume coal-fired power generation.
However, those companies that embrace these decarbonization goals are more resilient to climate risk, with more resilient business models, especially in the long term.
ETFs focused on climate change
This idea, along with increased investor interest in the wake of the coronavirus pandemic, means that fund managers are expanding their range of socially responsible vehicles with climate change funds and ETFs.
Amundi has just expanded its ETF range. These are the Amundi Euro iSTOXX Climate Paris Aligned PAB UCITS ETF, the Amundi MSCI Europe Climate Paris Aligned PAB UCITS ETF and the Amundi MSCI World Climate Paris Aligned PAB UCITS ETF2.
Thus, this family of funds incorporates a 50% reduction in carbon intensity along with additional activity exclusions.
It is fully complementary to the existing Amundi climate change ETFs, which are expected to meet the criteria of the EU Climate Transition Benchmarks (CTB) and designed for those investors who want a transition to a low carbon economy while maintaining broad market exposure.
However, it is not the only one. Lyxor is also expanding its range of climate change ETFs, with four new ones that exclude companies active in the coalfields from their investment spectrum, and above certain thresholds for carbon-intensive oil, natural gas, and electricity production.
They also avoid companies that undermine the EU’s environmental goals and those involved in controversial weapons, tobacco or violating social standards.
Arnaud Llinas, head of Lyxor ETF & Indexation, justifies these launches by reminding that “the EU’s climate benchmarks are just one way in which Europe is taking a lead on climate.”
Reticence towards green bonds
Green bonds are also playing a major role in this interest in climate change. However, investors are less likely to invest in these corporate bonds.
That is because fixed-income investors were already skeptical of stranded bonds in their early days of trading because of the need for a regulatory framework that defines the eligibility criteria for the use of proceeds from such stranded bonds. That includes the minimum energy improvements to be achieved, how these should be quantified and disclosed, and the extent to which the transaction should be subject to the issuer’s overall transition strategy.
Only in this way will it be possible to gain the confidence of investors and allow the transition bonds to become a more accepted market.
With the right framework in place, energy transition bonds could drive the next evolution in terms of capital allocation towards a low carbon economy.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in finanzas.com, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
How to create an Email marketing campaign your audience will love
Whether you sell a product or service, work from a home office or a corporate one, starting an email campaign...
Top 10 Forex Risks To Consider Before Starting Currency Trade
This article shows you the fx risk to expect while performing forex trade and how to mitigate them and ensure...
Why are investments in the fintech sector set to break records this year
The fintech sector has had a great year so far, according to investor Humberto Herrera Rincón Gallardo, who thinks that...
Biotech companies are getting closer to find the eagerly awaited COVID-19 vaccine
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of...
Switzerland returns $35.6 million to cannabis light producers
Swiss companies producing light cannabis products have received $35.6 million (€30 million) from the customs authorities for illegal taxes previously...
Biotech6 days ago
The Spanish pharma sector increased its profit by 18.4% in the first semester of the year
Business6 days ago
The financial guide for newlywed millennials
Featured5 days ago
The Italian fintech company Fido closes a €1.1 million financing round
Business5 days ago
PR Tech: How investments in the media market changed?